Cargando…

Real-World Effectiveness of SARS-CoV-2 Vaccine Booster in Hemodialysis Patients with COVID-19 Receiving Molnupiravir

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine booster is one of the most essential strategies against coronavirus disease 2019 (COVID-19) in the era of emerging variants. However, the effectiveness of SARS-CoV-2 vaccine boosters has not much been investigated in hemodialys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Po-Chun, Huang, Chiang-Chi, Fu, Chung-Ming, Chang, Yi-Chin, Wu, Po-Jung, Lee, Wen-Chin, Lee, Chien-Te, Tsai, Kai-Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967999/ https://www.ncbi.nlm.nih.gov/pubmed/36851757 http://dx.doi.org/10.3390/v15020543

Ejemplares similares

Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis
por: Chang, Yi-Chin, et al.
Publicado: (2023)

Molnupiravir—A Novel Oral Anti-SARS-CoV-2 Agent
por: Lee, Ching-Chi, et al.
Publicado: (2021)

Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
por: Flisiak, Robert, et al.
Publicado: (2022)

Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting
por: Kwok, Wang Chun, et al.
Publicado: (2023)

Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel
por: Weil, Clara, et al.
Publicado: (2023)

Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
por: Flisiak, Robert, et al.
Publicado: (2022)

Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients
por: Wu, Po-Jung, et al.
Publicado: (2018)

Comparative Adverse Kidney Outcomes in Women Receiving Raloxifene and Denosumab in a Real-World Setting
por: Chen, Hsin-Wei, et al.
Publicado: (2022)

Gelsolin and Progression of Aortic Arch Calcification in Chronic Hemodialysis Patients
por: Chiou, Terry Ting-Yu, et al.
Publicado: (2016)

Changes of immunogenic profiles between a single dose and one booster influenza vaccination in hemodialysis patients – an 18-week, open-label trial
por: Chang, Yu-Tzu, et al.
Publicado: (2016)

Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment
por: Su, Po‐Lan, et al.
Publicado: (2019)

The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients
por: Fu, Chung-Ming, et al.
Publicado: (2022)

Molnupiravir Outpatient Treatment for Adults with COVID-19 in a Real-World Setting—A Single Center Experience
por: Czarnecka, Kinga, et al.
Publicado: (2022)

Heart Rate Variability Change Before and After Hemodialysis is Associated with Overall and Cardiovascular Mortality in Hemodialysis
por: Chen, Szu-Chia, et al.
Publicado: (2016)

Safety and efficacy of molnupiravir in SARS‐CoV‐2‐infected patients: A real‐life experience
por: De Vito, Andrea, et al.
Publicado: (2022)

Validation of Gait Measurements on Short-Distance Walkways Using Azure Kinect DK in Patients Receiving Chronic Hemodialysis
por: Tsai, Zhi-Ren, et al.
Publicado: (2023)

Recurrent tertiary hyperparathyroidism due to supernumerary parathyroid glands in a patient receiving long-term hemodialysis: a case report
por: Tai, Tsai-Sung, et al.
Publicado: (2019)

Biomarkers Associated with Vascular and Valvular Calcification in Chronic Hemodialysis Patients
por: Lee, Chien-Te, et al.
Publicado: (2013)

Real world clinical performance of SARS-CoV-2 rapid antigen tests in suspected COVID-19 cases in Taiwan
por: Tsai, Shao-Chen, et al.
Publicado: (2021)

Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022)

Computational Analysis of Molnupiravir
por: Sharov, Artem V., et al.
Publicado: (2022)

Molnupiravir for COVID-19
Publicado: (2022)

Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence
por: Karniadakis, Ioannis, et al.
Publicado: (2023)

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
por: Chiang, Hsueh-Chien, et al.
Publicado: (2023)

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic
por: Suzuki, Yasuhito, et al.
Publicado: (2022)

Molnupiravir as an Early Treatment for COVID-19: A Real Life Study
por: Pontolillo, Michela, et al.
Publicado: (2022)

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
por: Kabinger, Florian, et al.
Publicado: (2021)

Decoding molnupiravir-induced mutagenesis in SARS-CoV-2
por: Menéndez-Arias, Luis
Publicado: (2021)

Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
por: Sun, Hsin-Yun, et al.
Publicado: (2022)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
por: Liang, Yankun, et al.
Publicado: (2023)

Real-World Use of Molnupiravir in the Treatment of Outpatients with SARS-CoV-2 Infection—A Patient Profile Based on the Experience of a Tertiary Infectious Disease Center
por: Streinu-Cercel, Anca, et al.
Publicado: (2022)

Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World Study
por: Yang, Chin-Yi, et al.
Publicado: (2022)

Healthcare worker access to molnupiravir: A case series
por: O’Keeffe, Jessica C., et al.
Publicado: (2023)

Clinical assessment of resting full-cycle ratio and fractional flow reserve for coronary artery disease in a real-world cohort
por: Chuang, Ming-Ju, et al.
Publicado: (2022)

Egyptian hemodialysis patients' willingness to receive the COVID-19 vaccine booster dose: a multicenter survey
por: Abdulaziz, Hoda Mahmoud Mohammad, et al.
Publicado: (2023)

Clinical outcomes of Atezolizumab Therapy for Previously-Treated Advanced-Stage Non-Small Cell Lung Cancer: A Real-World Study in Taiwan
por: Wu, Shang-Gin, et al.
Publicado: (2022)

Correlation of sociodemographic profiles with psychological problems among hospitalized patients receiving unplanned hemodialysis
por: Kao, Yu-Yin, et al.
Publicado: (2020)

Risk Factors and Incidence Rates of Self-Reported Short-Term Adverse Events of COVID-19 Vaccine Booster Dose
por: Chen, Po-Yu, et al.
Publicado: (2022)

Lingual amyloidosis in a long-term hemodialysis patient
por: Chen, Chien-Chin, et al.
Publicado: (2018)

Ultrasonography Measurement of Renal Dimension and Its Correlation with Age, Body Indices, and eGFR in Type 1 Diabetes Mellitus Patients: Real World Data in Taiwan
por: Su, Hsuan-An, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lj862g80fhat81g8e1vigkn5rj